Dec 1, 2022 | 2022, Press Releases, Scientific
The management team to hold a Webinar on Dec 1, 2022, at 10:00 ET / 15:00 GMT / 16:00 CET (Please find the link for the webinar here). Corporate_Update_Dec 1Nov 28, 2022 | 2022, Investors, Press Releases
More detailsNov 21, 2022 | 2022, Investors, Press Releases
More detailsNov 18, 2022 | 2022, Press Releases, Scientific
The study describes the development of a novel anti-PD-1 antibody that shows potent blockade of PD-1 with a different recognition mechanism compared to anti-PD-1 antibodies that have recently reached the market. For more detailsNov 14, 2022 | 2022, Investors, Press Releases
More detailsNov 11, 2022 | 2022, Press Releases, Scientific
The study describes the discovery of GCPIII as the protein responsible for the accumulation of conventional PSMA targeting agents in healthy organs. More details
Recent Comments